Teceris 0.5 mg Injection
$361.28
$281.80
Teceris 0.5 mg Injection is a targeted anticancer therapy designed for patients grappling with metastatic breast cancer who have undergone at least two previous chemotherapy treatments. Additionally, it is indicated for individuals with unresectable liposarcoma who have received prior therapy containing anthracyclines, provided they are not unsuitable for treatment. This medication functions by effectively inhibiting the proliferation and dissemination of cancer cells, thereby helping to manage disease progression. Patients receiving Teceris should be aware of potential side effects, including but not limited to fatigue, nausea, and hematologic changes, necessitating regular monitoring throughout treatment. It's essential for healthcare providers to assess a patient’s medical history and concurrent medications to avoid adverse interactions. As with any cancer therapy, ongoing communication with the healthcare team is vital to optimize treatment outcomes. With its specific indications and mechanism of action, Teceris 0.5 mg Injection plays a crucial role in the therapeutic arsenal against advanced malignancies. For those seeking effective management of their condition, this injection offers a promising option in the fight against cancer.
Quantity
Active Pharmaceutical Ingredient
Uses
• Teceris 0.5 mg injection is primarily utilized in the treatment of metastatic breast cancer. This condition often results in pain or discomfort in various areas, such as the bones or chest. By addressing these symptoms, Teceris 0.5 mg injection helps improve the quality of life for patients. It is a crucial component in the management of this advanced stage of cancer.
• Patients experiencing swelling or difficulty in breathing due to metastatic breast cancer may benefit from Teceris 0.5 mg injection. The medication aids in alleviating these distressing symptoms, providing relief to those affected. Additionally, it can assist in managing persistent cough or wheezing that often accompanies the disease. As such, Teceris 0.5 mg injection plays a significant role in comprehensive cancer care.
• Teceris 0.5 mg injection is also effective in addressing issues related to appetite loss and weight reduction often seen in metastatic breast cancer patients. By mitigating these symptoms, the injection contributes to better nutritional status and overall well-being. This is particularly important for maintaining strength during treatment. The use of Teceris 0.5 mg injection can thus support patients in their cancer journey.
• In cases where nausea or vomiting is a concern, Teceris 0.5 mg injection can be an essential part of the treatment regimen. It helps manage these side effects, allowing patients to tolerate their overall therapy better. By focusing on symptom relief, Teceris 0.5 mg injection enhances the patient's ability to continue with their prescribed cancer treatment. This supportive care is vital for those battling metastatic breast cancer.
Benefits
Metastatic breast cancer is a type of advanced breast cancer that has spread beyond the breast and nearby lymph nodes to other parts of the body, such as the bones, liver, lungs, or brain. Teceris 0.5 mg Injection is used when other medicines have not shown significant improvement and cancer has spread to other parts as well. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Teceris 0.5 mg kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
Soft tissue sarcoma (Liposarcoma): soft tissue sarcoma is a group of cancers that develop in the soft tissues of the body, such as the muscles, fat, nerves, blood vessels, and connective tissues. This medicine is used who have received prior anthracycline-containing therapy and have not shown significant improvement. Teceris 0.5 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
Side Effects
Teceris 0.5 mg Injection may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Breathlessness
• Risk of Infection
• Loss of appetite
• Headaches
• Numbness or tingling in toes and fingers
• Cough
• Feeling sick
• Diarrhoea
• Constipation
• Hair loss
• Body Pain
• Fever
• Fatigue
• Weight loss
Common Side Effects
• Sepsis
• Blood clot in veins
• Inflammation of the pancreas
• Liver Damage
• Protein and blood in your urine
• Severe skin reaction
• Bruising and bleeding
• Changes in heartbeat
How To Use
Teceris 0.5 mg is given intravenously (in vein) or as an intravenous infusion over 2 to 5 minutes by a healthcare professional, doctor or nurse in a hospital. The dosage and frequency of Teceris 0.5 mg depend on various factors, including your weight and height, your health problems and what type of cancer and condition you have. Your health professional may decrease your dose or delay your treatment if you experience serious side effects. While during the treatment closely monitor the patient while blood cell count, peripheral neuropathy signs and symptoms.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Teceris 0.5 mg Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: patients with kidney disease should closely monitor kidney function while taking Teceris 0.5 mg and report any unusual symptoms or changes in kidney function to their physician. The dose of Teceris 0.5 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Teceris 0.5 mg. Teceris 0.5 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Teceris 0.5 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Teceris 0.5 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Teceris 0.5 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Teceris 0.5 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Teceris 0.5 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Teceris 0.5 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Teceris 0.5 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Teceris 0.5 mg.